- Home
- CLOV
as 07-26-2024 4:00pm EST
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN |
| Market Cap: | 645.4M | IPO Year: | N/A |
| Target Price: | $1.50 | AVG Volume (30 days): | 3.7M |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.61 - $1.78 | Next Earning Date: | 08-05-2024 |
| Revenue: | $1,852,867,000 | Revenue Growth: | -36.64% |
| Revenue Growth (this year): | -32.68% | Revenue Growth (next year): | 3.14% |
Stock Insider Trading Activity of Clover Health Investments Corp. (CLOV)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Garipalli Vivek | CLOV | Director10% Owner | Jun 17 '24 | Buy | $1.14 | 877,567 | $1,000,426.38 | 877,567 | SEC Form 4 |
| Loengard Anna U | CLOV | Director | May 16 '24 | Buy | $0.93 | 10,000 | $9,300.00 | 10,000 | SEC Form 4 |
| Loengard Anna U | CLOV | Director | May 16 '24 | Buy | $0.96 | 15,600 | $14,976.00 | 15,600 | SEC Form 4 |
| Loengard Anna U | CLOV | Director | May 16 '24 | Buy | $0.94 | 1,485 | $1,395.90 | 15,110 | SEC Form 4 |
| Loengard Anna U | CLOV | Director | Mar 14 '24 | Buy | $0.73 | 137,000 | $100,010.00 | 538,841 | SEC Form 4 |
| Loengard Anna U | CLOV | Director | Mar 14 '24 | Buy | $0.73 | 13,625 | $9,946.25 | 15,125 | SEC Form 4 |
Latest Clover Health Investments Corp. News
CLOV Breaking Stock News: Dive into CLOV Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference
GlobeNewswire
4 days ago
Clover Health to Report Second Quarter 2024 Financial Results on August 5
GlobeNewswire
a month ago
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
Yahoo Finance Video
a month ago
Nvidia slips, home prices reach a record high: Yahoo Finance
GlobeNewswire
a month ago
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year
Simply Wall St.
2 months ago
Clover Health Investments, Corp.'s (NASDAQ:CLOV) largest shareholders are retail investors with 58% ownership, insiders own 24%
GlobeNewswire
2 months ago
Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers
Yahoo Finance
2 months ago
Why the 2024 meme stock action is much tamer than 2021 — so far
Compare CLOV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLOV Clover Health Investments Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.